Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma × Radiation Dose Hypofractionation × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Gallbladder Neoplasms 1 Encopresis 1 Cholangiocarcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Neoplasms 1 Breast Carcinoma In Situ 1

Interventions

Specimen Handling 9 Magnetic Resonance Spectroscopy 7 Doxorubicin 7 Biopsy 7 Gemcitabine 5 X-Rays 4 Phantoms, Imaging 4 tazemetostat 3 pembrolizumab 3 liposomal doxorubicin 3 Radiotherapy 3 Ifosfamide 3 ulixertinib 2 palbociclib 2 ivosidenib 2 ensartinib 2 Surveys and Questionnaires 2 Standard of Care 2 Radiosurgery 2 Radiation 2 Nuclear Medicine Department, Hospital 2 Nivolumab 2 LY3023414 2 Fluorodeoxyglucose F18 2 Docetaxel 2 Cyclophosphamide 2 Albumin-Bound Paclitaxel 2 trastuzumab deruxtecan 1 toripalimab 1 tipifarnib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05917301 2026-04-17

PRONTO

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase NA Recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡